Hereditary hemochromatosis
MONDO:0006507An inherited metabolic disorder characterized by iron accumulation in the tissues.
Also known as: haemochromatosis, hemochromatosis, hemochromatosis, hereditary
9 clinical trials for this condition and its sub-types, 8 tagged with Hereditary hemochromatosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Hereditary hemochromatosis
-
Hemochromatosis type 1 3 trials
-
African iron overload 0 trials
-
Digenic hemochromatosis 0 trials
-
Hemochromatosis type 2 0 trials
2 sub-types
- Hemochromatosis type 2A 0 trials
- Hemochromatosis type 2B 0 trials
-
Hemochromatosis type 3 0 trials
-
Hemochromatosis type 4 0 trials
-
Hemochromatosis type 5 0 trials
-
Neonatal hemochromatosis 0 trials
-
New pill could ease iron overload for thousands with genetic disorder
Disease control Recruiting nowThis phase 2 trial tests an experimental drug called vamifeport in 84 adults with HFE-related hereditary hemochromatosis, a genetic condition causing iron buildup. The drug aims to reduce liver iron levels, potentially offering an alternative to regular blood removal. Participant…
Phase 2 • Sponsor: CSL Behring • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New pill aims to tame iron overload in genetic disorder
Disease control Recruiting nowThis early-stage trial tests an oral drug called BBI-001 for hereditary hemochromatosis, a condition where the body stores too much iron. The study has two parts: one checks safety in healthy volunteers, and the other measures how well the drug controls iron levels in patients. A…
Phase 1/2 • Sponsor: Bond Biosciences • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC